| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XSTU Exchange | US0885792061 ISIN |
| Bangladesh Country | 5,500 Employees | 22 Nov 2024 Last Dividend | 23 Nov 2020 Last Split | - IPO Date |
Beximco Pharmaceuticals Limited, established in 1976 and headquartered in Dhaka, Bangladesh, stands as a notable entity in the pharmaceutical industry. The company specializes in manufacturing and marketing a broad spectrum of generic pharmaceutical formulations and active pharmaceutical ingredients. Catering to both the local market in Bangladesh and international clientele, Beximco Pharmaceuticals Limited ensures a significant presence in the global pharmaceutical landscape. Furthermore, the company extends its proficiency by offering contract manufacturing services, thereby supporting other companies within the pharmaceutical sector.
The range of products and services offered by Beximco Pharmaceuticals Limited caters to a diverse array of medical needs and pharmaceutical requirements:
Each product category is formulated in various dosage forms including sold, liquid, cream and ointment, suppositories, metered dose and dry powder inhalers, nasal sprays, sterile, lyophilized injectables, and large volume intravenous fluids, showcasing Beximco Pharmaceuticals Limited’s versatile manufacturing capabilities.